Using a gonadotropin-releasing hormone (GnRH) analog, ] desGly10-GnRH-N-ethlamide (GnRHa) as a ligand the binding capacity of the rat ovary to GnRH during sexual maturation and the mechanism regulating GnRH binding capacity were examined.
The tissue specificity of GnRHa binding is shown in Fig. 1 . 125I-GnRHa bound to various tissues of rats (28 days Effects of PMSG administrations in DES primed hypophysectomized rats In order to exclude the effects of endogenous pituitary hormones, DES primed hypophysectomized rats were utilized. To characterize the binding capacity of GnRH to functionally active follicular tissue, DES primed immature hypophysectomized rats were treated with various concentrations of PMSG (10-200 iu). With these treatments, uniform antral follicles were microscopically observed in the ovary. The administrations of various concentrations of PMSG increased ovarian wet weight significantly (p <0.01, compared to the control group) as shown in Fig. 4 treated) DES primed rats as shown in Fig.  8 . In the residual tissue from GnRH treated rats, PMSG induced a reduction in GnRH binding capacity, being similar to that found in non-treated rats, but in the granulosa cells increasing doses of PMSG increased GnRH binding capacity, as shown in Fig. 8 . That is, in the residual tissue, PMSG had more potent effects on GnRH binding capacity than GnRH had and in the granulosa cells GnRH in combination with PMSG had stimulatory effects on GnRH binding capacity. The concentration of GnRH in the portal blood system of the rat has been reported to be 50-500 pg/ml (Eskay et al., 1975) . These concentrations are comparable with the affinity of the GnRH binding sites in the pituitary, but GnRH is diluted 1 : 500 between the portal circulation and the peripheral vein (Nett et al., 1974) . Their concentrations in peripheral plasma do not seem to interact with a receptor having an affinity of 109M-1. GnRH like substance has been found in ovarian follicular fluid (Ying et al., 1981) , human placenta tissue (Khodr and Siler-Khodr, 1980) , parasynpathetic ganglion of the frog (Jan et al., 1979) and in the testis (Sharp and Fraser, 1980) . This GnRHlike peptide present in the ovary may bind to the GnRH receptor and be involved in local regulation of the ovarian function. During sexual maturation, GnRH binding capacity was very low at 7 days of age and increased thereafter. From day 28, the concentration of ovarian GnRH receptors gradually decreased during the prepubertal period to reach the adult level. Serum FSH concentrations in female rats reached on extremely high level between 10 and 15 days of age and then declined. Smith-White and Ojeda (1981) found that the ovarian steroidogenic activation that preceded the first surge of gonadotropins in the rat was associated with a marked loss in ovarian. GnRH receptor content. These results suggested that the presence of high levels of ovarian GnRH receptors prevented follicular maturation around 28 days of age and that a diminished binding capacity of GnRH permitted an acceleration of ovarian sensitivity to gonadotropins just before puberty.
The mechanism of regulating GnRH binding capacity is not yet known. Marshall et al. (1981) found that pituitary GnRH receptor was increased by exposure to GnRH, and gonadotropins seem to modify the GnRH binding judging from our findings on sexual maturation. Therefore, we examined the effect of GnRH on GnRH binding capacity in intact and in DES primed hypophy-sectomized immature rats. The treatment with PMSG was found to decrease the concentrations of ovarian GnRH receptors on the whole ovary of intact and hypophysectomized immature rats. These findings are in agreement with the results reported by Labrie et al. (1982) and Harwood et al. (1980) . This inhibition of GnRH binding capacity by PMSG administration is consistent with the findings of the loss of GnRH binding capacity before puberty as ovaries stimulated by PMSG had many active antral follicles. In order to determine the degree of GnRH binding capacity in the granulosa cells, these cells were divided from the ovary as specific changes in the granulosa cells might be masked when the binding capacity of GnRH in the whole ovary was investigated. The binding capacity of GnRH after PMSG administration markedly decreased in the residual tissue as well as in whole ovaries, but the binding capacity did not change in the granulosa cells. This result indicates that the binding capacity in the whole ovary represents the binding capacity in the residual tissue rather than in the granulosa cells.
Repeated injections of GnRH caused significant increases in GnRH receptors of whole ovaries in PMSG-treated intact rats. The granulosa cells also exhibited an increase in GnRH binding capacity and a decrease in HCG binding capacity, and these cells had a greater increase in binding capacity than the residual tissue did. In GnRHtreated DES primed hypophysectomized rats, increasing doses of PMSG increased GnRH binding capacity in the granulosa cells but decreased the binding capacities in the residual tissue.
These results indicated that GnRH in combination with PMSG had stimulatory effects on GnRH binding capacity and seemed to increase the sensitivity to GnRH, that an inverse correlation might exist between the GnRH binding capacity and the HCG binding capacity, and that the mechanism regulating GnRH binding capacity in the granulosa cells seemed to be different from the mechanism in the residual tissue.
